市場今すぐ寄付してください会員になる

カート (0)

DIAアカウントをお持ちの場合、サインインしてください。

サインイン

ユーザーIDをお忘れですか？ or パスワードをお忘れですか？

Not a Member?

アカウントを作成して参加。

世界的なイベント

Tokyo Big Sight

2016年11月13日 (日) 午前 9:30 - 2016年11月15日 (火) 午後 5:30

3-11-1 Ariake, Koto-ku, Tokyo, 135-0063 Japan

13th DIA Japan Annual Meeting 2016

戻る Agenda

[V5-S2] How to Provide Drug Information from a Standpoint of a Patient (Part 1)

Session Chair(s)

Yuko Kojima, RPh

Yuko Kojima, RPh

Sr. Executive Director, Eli Lilly Japan K.K., Japan

Mamoru Narukawa, PhD, RPh

Mamoru Narukawa, PhD, RPh

Professor, Kitasato University, Japan

Determining what information patients and medical experts need, and how to make the information available to ensure proper drug use, is an essential issue. We will discuss various medical communication tools created by the pharmaceutical industry to encourage appropriate drug use (i.e., for medical experts, package inserts, interview forms, and guides for appropriate use; for patients, drug guides, and drug information sheets). This session will review the current situation, issues, and practice in Japan, discussed by speakers from the pharmaceutical industry, regulatory agencies, and HCPs. We will also exchange views on what information patients and medical experts need, and how to make this information available.

Speaker(s)

Tomoko Tanita

Risk Communication Promotion Division, Office of Safety I, Pharmaceuticals and Medical Devices Agency (PMDA), Japan

The Regulations of Drug Information Provision and its Challenges - From the Regulatory Agencies' Perspective

Junichi Nishino, MSc, RPh

Junichi Nishino, MSc, RPh

Head, Regulatory Affairs Department, Otsuka Pharmaceutical Co., Ltd., Japan

The Current Status and the Issue of Drug Information Provision from the Pharmaceutical Industry Perspective

Masahiro Hayashi, PhD

Pharmaceutical affairs specialist, Department of Pharmacy, Toranomon Hospital, Japan

The Current Status of the Providing Drug Information and Issue of the Medical Communication - The Point of View from Medical Site